Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Orchard & SIRION Enter License Agreement
SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™12.14.18
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CTI BioPharma Corp. Restructures
Workforce reductions have been implemented that impact approximately 50 percent of the company's employees12.14.18
-
Bio News | Drug Development | Facilities | Industry News | Promotions & Moves | R&D
HemaCare Moves Into New HQ
Company has officially moved its global headquarters to Northridge, California, in a 40,000 sq. ft. building in the heart of the San Fernando ValleyVideos
-
Breaking News | Clinical Trials | CRO News | Drug Development | Promotions & Moves
PPD Adds New Therapeutic Area Leaders
Enhances drug development capabilities in cardiovascular disease, critical care, endocrinology, metabolism and diabetes12.13.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Q BioMed, SRI Enter ASD Collaboration
To provide formulation development, preclinical development, and early clinical manufacturing of QBM-001 for non-verbal or minimally verbal autistic children12.13.18
-
Breaking News | Collaborations & Alliances | Drug Development
Celgene Licenses Two Dragonfly Immunotherapy Candidates
The licenses represent the first two of four hematological cancer targets from the companies' June 2017 collaboration12.13.18
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Novo Nordisk Purchases Berkeley Lights Beacon Platform
Aims to reduce the extensive resources typically required to generate a cell line for commercial production12.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Industry News | Solid Dosage/Semi-solids
Federal Equipment & Investor Group Purchase Pharma Campus
The 110 acre, 800,000 sq. ft. site's features & capabilities include solid dosage form, liquid manufacturing filling, distribution warehouse, and vault storage12.11.18
-
Breaking News | Clinical Trials | CRO News | Drug Development
Rho Adds Regulatory Strategy and Submissions Biz
Will support sponsors in planning, developing and submitting marketing applications12.11.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
CBT & Strata Oncology Enter Development Deal
To drive patient enrollment in CBT’s ongoing Phase 1/2 trial of CBT-101 in patients with c-Met dysregulated malignancies including non-small cell lung cancer12.10.18
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
BlueRock, McEwen Stem Cell Institute Expand Alliance
New, 14,000 sq.-ft. lab expands operations and infrastructure12.07.18
-
Breaking News | Clinical Trials | Drug Development | Industry News
Eisai, UCL Alliance Advances Alzheimer's Candidate
Phase I trial of E2814, an anti-tau monoclonal antibody, will assess the ability to slow the progression of AD12.07.18
-
Breaking News | Collaborations & Alliances | Drug Development
Fimbrion, GSK Research Alliance Identifies Novel UTI Treatment
Candidate represents a new strategy for treating bacterial infections12.06.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Icagen & Roche Partner for Neurological Therapy
Will develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders12.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Evotec & LEO Pharma Partner for Drug Discovery
To generate new leads against innovative targets for a range of dermatological conditions12.04.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
iDD Biotech Receives Second Milestone
Milstone was initiated after its partner, Genmab, started a Phase I/IIa trial of GEN102912.04.18
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
argenx, Janssen Enter $1.6B Cancer Drug Deal
Collaboration to develop cusatuzumab in AML, MDS and other hematological malignancies12.03.18
-
Drug Development | Drug Discovery | Industry News
Developing Translational Biologics for Brain Disorders
The future of CNS therapiesAntti Nurmi, Charles River Discovery Services, Kuopio, Finland 11.30.18
-
Bio News | Biologics, Proteins, Vaccines | Drug Development | Facilities | Industry News | R&D
GE Launches Biotechnology Mfg. Center
To produce a purification platform for efficiency in purification of mfg. biopharmaceuticals, gene therapies & viral vectorsVideos
